THE REVISED COMMON RULE: WHAT S NEXT?
|
|
- Timothy Heath
- 6 years ago
- Views:
Transcription
1 THE REVISED COMMON RULE: WHAT S NEXT? November 15, HURON CONSULTING GROUP INC.
2 THE REVISED COMMON RULE: WHAT S NEXT? 2 1 Introductions & Information 4 Proposal to Delay the Final Rule 2 General Notes 5 Planning Ahead 3 Key Takeaways from Previous Webinars 6 Q&A 2017 HURON CONSULTING GROUP INC. AND AFFILIATES. ALL RIGHTS RESERVED.
3 1 INTRODUCTIONS & INFORMATION HURON CONSULTING GROUP INC.
4 TODAY S MODERATOR + GARY WHITNEY + Managing Director + Huron s Education Practice Experience: Gary has 30+ years experience in software and technology products. He assists clients with automation and deployment strategies in the areas of research compliance, grants and contracts administration and clinical trials management. Prior to joining Huron, Gary served as the VP of sales and marketing for Click Commerce. He cofounded Click Commerce s.com predecessor, Webridge, an enterprise web-based solutions startup HURON CONSULTING GROUP INC. AND AFFILIATES. ALL RIGHTS RESERVED.
5 TODAY S PRESENTERS FRANK CONTE T E fconte@huronconsultinggroup.com + Frank is a Director in Huron s Research Enterprise Solutions practice. He has more than fifteen years of project management experience in higher education. He focuses on assisting higher education and healthcare organizations with research administration initiatives including human research protection program and institutional review board (IRB) evaluation and process improvement, research administration system software selection, design and implementation and clinical research program evaluations. Frank is on the Huron IRB product advisory committee. 5 JONATHAN HUNTER T E jhunter@huronconsultinggroup.com 2017 HURON CONSULTING GROUP INC. AND AFFILIATES. ALL RIGHTS RESERVED. + Jonathan is a Manager in Huron s Research Enterprise Solutions practice. His work focuses on institutional review board (IRB) structure and function and human research protection program (HRPP) evaluation and accreditation. He has worked directly for or partnered with a wide range of institutions to implement policies and procedures designed to improve the efficiency and effectiveness of the IRB review process. Jonathan is also on the Huron IRB software solution product advisory committee, serves as the IRB Solution Lead for that product, and is part of the team responsible for maintaining Huron s HRPP Toolkit.
6 ASK US YOUR QUESTIONS: LEVEL 3 CHAT PANEL Enter a question in this dialog area at any time.
7 WHO IS ATTENDING THE WEBINAR TODAY? Primary job function: Sponsored Programs 5 % Other 28% Compliance 48.1% IT 9.9% Executive Leaders 9%
8 WHO IS ATTENDING THE WEBINAR TODAY? Level of research expenditures last year: $100 - $200M 17.8% $200 - $500M 17.8% Under $100M 53% $500M+ 11.4%
9 WHO IS ATTENDING THE WEBINAR TODAY? Where are you in the planning process for the revised Common Rule? Not started 7.3% Put on hold 2.6% Beginning Implementation 9.9% Developing revised policies and procedures 51.6% Reviewing the revised Common Rule 28.6%
10 POLLING QUESTION 1
11 2 GENERAL NOTES HURON CONSULTING GROUP INC.
12 REVISED COMMON RULE: DISCLAIMER The material presented today should be considered a work in progress, based upon our current understanding of the Revised Common Rule. We will continue to update our approach as guidance and other official information is released HURON CONSULTING GROUP INC.
13 REVISED COMMON RULE TERMINOLOGY Terms Current Rule; Pre-2018 Rule Final Rule; New Rule; 2018 Rule; Revised Rule; Revised Common Rule NPRM, Revision to the New Rule NIH Single IRB Policy Definition Current set of Common Rule regulations that IRBs follow Updated Common Rule, effective January 19, 2018 (except for collaborative research, effective January 20, 2020) The request to delay the Final Rule, posted to the Office of Management and Budget (OMB) website on October 7, 2017 Policy requiring Single IRB Review of multi-site research, effective January 25, HURON CONSULTING GROUP INC.
14 POLLING QUESTION 2
15 3 KEY TAKEAWAYS: PREVIOUS WEBINARS HURON CONSULTING GROUP INC.
16 KEY TAKEAWAYS +July 19, 2017: Prepare Your IRB Operations for Your IRB Operations for The Revised Common Rule - Making the switch Considerations for moving studies from the Current Rule to the New Rule - Broad Consent - Continuing Review for expedited projects - Planning ahead and timeline for implementation +September 20, 2017: Achieve IRB Operations Success for The Revised Common Rule - System-related considerations - Further discussion on Broad Consent - Benign behavioral interventions - Planning ahead and timeline for implementation HURON CONSULTING GROUP INC.
17 REVISED COMMON RULE TIMELINE 1/19/17 Release of the Final Rule from OHRP First major update to the Common Rule since the 90s 1/19/18 Effective and Compliance date for the Final Rule All research approved on or after this date must follow the Final Rule 1/25/18 Effective Date for the NIH Single IRB of Record Policy 1/?/19 Proposed delay to the Final Rule (General Implementation Date) 1/20/20 Compliance Date for the Final Rule Single IRB of Record Requirement HURON CONSULTING GROUP INC.
18 4 PROPOSAL TO DELAY THE FINAL RULE HURON CONSULTING GROUP INC.
19 WHAT WE KNOW: OMB REVIEW +Posted to the Office of Management and Budget (OMB) website on October 7: - Federal Policy for the Protection of Human Subjects: Proposed 1-Year Delay of the General Implementation Date While Allowing the Use of Three Burden-Reducing Provisions During the Delay Year HURON CONSULTING GROUP INC.
20 WHAT WE KNOW: TITLE OF THE PROPOSAL Federal Policy for the Protection of Human Subjects: Proposed 1-Year Delay of the General Implementation Date While Allowing the Use of Three Burden-Reducing Provisions During the Delay Year HURON CONSULTING GROUP INC.
21 WHAT WE DON T KNOW: A LOT! +What does General Implementation Date refer to? - This term does not appear anywhere in the Preamble or the text of the Final Rule itself. - This has a different meaning if OHRP is referring to the Effective Date or the Compliance Date (currently the same date). +What are the three burden-reducing provisions? - Are these the provisions requested by the AAMC, AAU, APLU, and COGR? HURON CONSULTING GROUP INC.
22 WHAT WE DON T KNOW: EFFECTIVE VS. COMPLIANCE DATE We understand there to be three possible scenarios depending on what General Implementation Date means: Possible Scenario 1: The Effective Date and Compliance Date are kept together and both are delayed by 1 year. The only provisions of the Final Rule that can be implemented prior to the new Effective and Compliance Date would be the three burden-reducing provisions. Possible Scenario 2: The Effective Date and Compliance Date are separated and the Compliance date is delayed by 1 year. But what is allowed is the same as in Possible Scenario 1. Possible Scenario 3: The Effective Date and Compliance Date are separated and the Compliance Date is delayed by 1 year. If an institution is ready, it may implement the entire Final Rule on of after 1/19/2018. Otherwise, an institution would be allowed to implement only the three burden-reducing provisions until ready to implement the entire Final Rule HURON CONSULTING GROUP INC.
23 WHAT WE DON T KNOW: POSSIBLE SCENARIO 1 11/15/2017 Revised Common Rule Webinar Possible Scenario 1 1/19/2018-1/21/ Burden-Reducing Provisions Only, All-In Only After New Date 1/21/2019 Proposed Effective and Compliance Date* 1/1/2018 4/1/2018 7/1/ /1/2018 1/1/ /15/2017 Current Effective and Compliance Date 1/21/2019 1/19/2018 *We selected 1/21/2019 because it is a Monday HURON CONSULTING GROUP INC.
24 WHAT WE DON T KNOW: POSSIBLE SCENARIO 2 11/15/2017 Revised Common Rule Webinar 1/19/2018 Proposed Effective Date Possible Scenario 2 1/19/2018-1/21/ Burden-Reducing Provisions Only, All-In Only After New Date 1/21/2019 Proposed Compliance Date* 1/1/2018 4/1/2018 7/1/ /1/2018 1/1/ /15/2017 Current Effective and Compliance Date 1/21/2019 1/19/2018 *We selected 1/21/2019 because it is a Monday HURON CONSULTING GROUP INC.
25 WHAT WE DON T KNOW: POSSIBLE SCENARIO 3 11/15/2017 Revised Common Rule Webinar 1/19/2018 Proposed Effective Date Possible Scenario 3 1/19/2018-1/21/2019 All-In If Ready, or 3 Burden-Reducing Provisions Only Until Ready 1/21/2019 Proposed Compliance Date* 1/1/2018 4/1/2018 7/1/ /1/2018 1/1/ /15/2017 Current Effective and Compliance Date 1/21/2019 1/19/2018 *We selected 1/21/2019 because it is a Monday HURON CONSULTING GROUP INC.
26 WHAT WE DON T KNOW: BURDEN-REDUCING PROVISIONS? In June 2017, the AAMC, AAU, APLU, and COGR requested to move forward with the following prior to the Effective Date (meaning, before January 19, 2018): - Certain exclusions and exemptions. - Elimination of the continuing review requirement for certain types or stages of research. - Elimination of IRB review of grant applications. What are the consequences of moving forward with any of the above provisions without implementing the entire Final Rule? - For example, certain exclusions and exemptions depend on other provisions in the Final Rule, e.g., Limited IRB Review. If the delay included the ability to move forward with certain exclusions and exemptions, how to move forward would need to be clarified. Our assumption, considering the complexity of the Final Rule, is that any provisions allowed during a delay period would need to be able to stand alone HURON CONSULTING GROUP INC.
27 POLLING QUESTION 3
28 POLLING QUESTION 4
29 FEDERAL RULE MAKING PROCESS WHERE ARE WE TODAY? HURON CONSULTING GROUP INC. Source: Office of Management and Budget,
30 FEDERAL RULE MAKING PROCESS NEXT STEPS HURON CONSULTING GROUP INC. Source: Office of Management and Budget,
31 EXAMPLE REGULATORY TIMELINE TODAY Nov. 16 Dec. 16 Jan. 16 Jan. 19 OMB Approves Posting of NPRM NPRM Published Comment Period Opens Comment Period Closes OHRP Compiles Comments OHRP Finalizes Rule and Obtains Signatures Delay to Final Rule Posted to Federal Register Assumptions: +Rule gets approved for posting by OMB today +30-day comment period +The OHRP is able to compile and respond to all comments within 30 days +Common Rule Agencies quickly sign-off on Final Rule +Final Rule gets posted to the Federal Register within 3 days of completing review and responding to comments +Not factoring in holidays or other potential delay factors HURON CONSULTING GROUP INC.
32 DON T FORGET OTHER INFLUENCING FACTORS +Thanksgiving, Christmas and New Year federal holidays all occur in our proposed timeline. +Other governmental factors, including timeline for the OMB review and sign-off from Common Rule Agencies. +Potential for a government shutdown in December HURON CONSULTING GROUP INC.
33 PROPOSED DELAY WHERE DOES THAT LEAVE US TODAY? Given the extremely aggressive timeline to post an official delay to the Final Rule before the Effective and Compliance date, it is not likely that the delay will go into effect by January 19. This leaves organizations with 2 options: - Option 1: Continue preparing to follow the Final Rule as it is currently posted in the Federal Register. - Option 2: Do nothing and expect that the Final Rule will be delayed HURON CONSULTING GROUP INC.
34 5 PLANNING AHEAD HURON CONSULTING GROUP INC.
35 PLANNING AHEAD HRPP PROCESS CHANGE HRPP Future State SOPs and Tools eirb Training Develop an approach to updating your SOPs and other tools to accommodate the 2018 requirements. Create a project plan for updating your IRB system; secure SME input and IT resources. Determine which groups need what training, and who will develop the curriculum and lead it HURON CONSULTING GROUP INC.
36 PLANNING AHEAD EXAMPLE TIMELINE - JULY WEBINAR 7/19/2017 Huron Revised Common Rule Webinar 1/19/2018 Revised Common Rule Effective Date 8/19/ /19/2017 Revise SOPs and other review tools 10/19/2017-1/19/2018 Train IRB staff, IRB members, and investigators 8/1/2017 9/1/ /1/ /1/ /1/2017 1/1/2018 7/19/2017 1/19/2018 8/19/ /19/ /19/2017-1/19/2018 7/19/2017-8/19/2017 Develop broad consent approach Revise investigator-facing materials and update IRB system Engage stakeholders/create comprehensive plan HURON CONSULTING GROUP INC.
37 PLANNING AHEAD NEW EXAMPLE TIMELINE (NO DELAY) 7/19/2017 Huron Revised Common Rule Webinar 9/20/2017 Huron Revised Common Rule Webinar 2 11/15/2017 Huron Revised Common Rule Webinar 3 12/17/2017-1/19/2018 Train IRB staff, IRB members, and investigators 11/15/ /16/2017 Revise SOPs and other review tools 8/1/2017 9/1/ /1/ /1/ /1/2017 1/1/2018 7/19/2017 1/19/ /17/2017-1/19/2018 Revise investigator-facing materials and update IRB system Don t panic. Prepare! Our goal throughout this series has been to help you prepare according to what we know. While a delay would ease the immediate burden, we still encourage you to be ready as soon as possible. Revised Common Rule Effective Date 11/15/ /2/2017 1/19/2018 Engage stakeholders/create comprehensive plan HURON CONSULTING GROUP INC.
38 POLLING QUESTION 5
39 Q&A HURON CONSULTING GROUP INC.
40 RESOURCES: + IRB Transformation Services & Product Information: + Huron NIH Single IRB Policy Thought Leadership: + Final revisions to the Common Rule: + The (R)evolution Can Wait: Implementation of Common Rule Updates May Be Delayed : - An article published on October 26, 2017 which discusses the possible delay. + SACHRP recommendations for broad consent, and draft template: Subscribe to our list for the most up-to-date webinars, news alerts and thought leadership on this topic: HURON CONSULTING GROUP INC.
41 CONTACT US FRANK CONTE DIRECTOR T E fconte@huronconsultinggroup.com JONATHAN HUNTER MANAGER T E jhunter@huronconsultinggroup.com GARY WHITNEY MANAGING DIRECTOR T E gwhitney@huronconsultinggroup.com HURON CONSULTING GROUP INC. AND AFFILIATES. ALL RIGHTS RESERVED.
42 THANK YOU!
STRATEGIES TO HELP FUTURE- PROOF YOUR IRB OPERATIONS
STRATEGIES TO HELP FUTURE- PROOF YOUR IRB OPERATIONS January 26, 2018 2018 HURON CONSULTING GROUP INC. STRATEGIES TO HELP FUTUREPROOF YOUR IRB OPERATIONS 2 1 Introductions & Information 4 Common Rule Delay
More informationEFFECTIVELY IMPLEMENTING THE NIH SINGLE IRB POLICY AND REVISED COMMON RULE
EFFECTIVELY IMPLEMENTING THE NIH SINGLE IRB POLICY AND REVISED COMMON RULE 2018 SRA MIDWEST/SOUTHERN SECTION MEETING ST. LOUIS, MO Wednesday, April 18, 2018 10:30 AM - 11:45 AM 2018 HURON CONSULTING GROUP
More informationThe Revised Common Rule
The Revised Common Rule Where Are We Now? What Happens Next? Heather Pierce, JD, MPH Senior Director, Science Policy Regulatory Counsel hpierce@aamc.org June 20, 2018 2018 AAMC. May not be reproduced without
More informationDeveloping a Written Reliance Agreement with a Central IRB
Developing a Written Reliance Agreement with a Central IRB 02/02/16 description One of the first steps for an institution that will defer IRB jurisdiction to another is to execute a reliance agreement.
More informationOutline of Discussion
This final rule is intended to better protect human subjects involved in research, while facilitating valuable research and reducing burden, delay, and ambiguity for investigators. These revisions are
More informationNIH Policy Priorities for Clinical Research
NIH Policy Priorities for Clinical Research Kathy Hudson, Ph.D. Deputy Director for Science, Outreach, and Policy, NIH Federal Demonstration Partnership January 12, 2015 Topics Clinical Trial Results Reporting
More informationActions to Reduce or Eliminate Administrative Burden in Research Compliance Human Subject Research
Software Solution Researcher Training ORC staff Board member Administrative Burden Only propose consent changes that are tied to regulation or subject's Returning consent forms for correction comprehension
More information2018 Common Rule Implementation Checklist
2018 Common Rule Implementation Checklist Action Items The following table outlines certain actions institutions should take or consider taking in light of the 2018 Common Rule s nowdelayed effective and
More information2013 Metrics on Human Research Protection Program Performance
2013 Metrics on Human Research Protection Program Performance Updated August 1, 2014 About the Metrics Improving the quality of human research protection programs (HRPP) is a top priority of AAHRPP. Effective
More informationThe Revised Common Rule. Ann Johnson, PhD, MPH IRB Director University of Utah
The Revised Common Rule Ann Johnson, PhD, MPH IRB Director University of Utah Objectives Describe the Changes that Affect the UU IRB What does this mean for ERICA? UPDATE: The postponement to January 2019
More informationQuality Assurance for the Research Team: Connecting Day-to-Day Operations to a Regulatory Framework
1 Quality Assurance for the Research Team: Connecting Day-to-Day Operations to a Regulatory Framework Mandy Morneault Research Compliance Monitor University of Washington Institute of Translational Health
More informationAdvancing the Use of Central IRBs for Multicenter Clinical Trials
Advancing the Use of Central IRBs for Multicenter Clinical Trials Cynthia Hahn, Chief Operating Officer, The Feinstein Institute for Medical Research July 10, 2015 CTTI Mission To identify and promote
More informationI don t get no respect! How to expand your influence & heighten your personal profile. Colorado Chapter Meeting August 13, 2012
I don t get no respect! How to expand your influence & heighten your personal profile Colorado Chapter Meeting August 13, 2012 Introduction Stumbled into proposal writing 12 years at Healthways, Inc. took
More information2018 Common Rule Implementation Checklist
2018 Common Rule Implementation Checklist High Priority Action Items The following table outlines certain actions institutions should consider taking ahead of the 2018 Common Rule s effective and general
More informationMonthly IRB-Investigator Meeting
Monthly IRB-Investigator Meeting December 20, 2018 Human Research Protection Office Institutional Review Boards Agenda Regulatory Changes Effective January 21, 2019 What you need to know What you should
More informationThe True Cost of Bad Hires
The True Cost of Bad Hires Kristen Wylie, SHRM-CP Product Marketing Director Workforce Ready Kronos Incorporated Daria Friedman Principal Analyst Talent Acquisition Brandon Hall Group Sponsored by: Kronos
More informationOregon ewic Implementation Lessons Learned. NWA Technology & Program Integrity Conference September 19, 2013
Oregon ewic Implementation Lessons Learned NWA Technology & Program Integrity Conference September 19, 2013 Oregon WIC Program 40 state program staff 4 state MIS developers 36 local agencies 112,000 participants
More informationRecommendations for Strengthening the Investigator Site Community
Recommendations for Strengthening the Investigator Site Community October 2017 CTTI MISSION: To develop and drive adoption of practices that will increase the quality and efficiency of clinical trials
More informationRe: Laboratory Animal Welfare: Draft Report on Recommendations to Reduce Administrative Burden on Researchers (83 FR 63268)
February 20, 2019 Patricia Brown, VMD, MS Office of Laboratory Animal Welfare Office of Extramural Research National Institutes of Health, Suite 2500 6700B Rockledge Drive Bethesda, MD 20892 6910 Re: Laboratory
More informationStandard Operating Procedures (SOPs)
Organizational Strategies for Clinical Trials Standard Operating Procedures (SOPs) SUSAN JACKSON, MPA UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL CENTER FOR GASTROINTESTINAL BIOLOGY AND DISEASE UNC CENTER
More informationSummary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015
Pediatric-Specific Provisions Summary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015 Requires the NIH to complete a strategic plan, and in the
More informationSubject line: Bristol-Myers Squibb Streamline processes with Tungsten e-invoicing
Subject line: Bristol-Myers Squibb Streamline processes with Tungsten e-invoicing Dear Valued Supplier, Several years ago, as part of our overall strategy to simplify processes, introduce innovation and
More informationProgram Orientation: Part 2 October 27, :00-2:30 p.m.
Program Orientation: Part 2 October 27, 2017 1:00-2:30 p.m. Cole Forstedt, MS Student Ambassador Program Manager Carly Smith Civic Engagement Specialist Participating Colleges Using Zoom To submit questions,
More informationDefining research compliance Protocol review committees Conflicts of interest Export Controls
Defining research compliance Protocol review committees Conflicts of interest Export Controls What is Research Compliance? Conformance with Federal, State, and Local Regulations and University Policies
More informationLearning about Clinical Trials
Learning about Clinical Trials A Guide for Individuals and Their Loved Ones INTRODUCTION Clinical trials help researchers answer important medical questions, providing information that may help with the
More informationUnderstanding the New Common Rule and Its Impact to Industry
Understanding the New Common Rule and Its Impact to Industry James Riddle MCSE, CIP, CPIA VP Client Services Kinetiq, a Division of Quorum Review IRB Impact to Industry Common Rule Applies only to Federally
More informationA Healthier You Reporting
A Healthier You Reporting Blue KC provides clients with participant information to facilitate communication campaigns and award employees incentives for completing program components. Personal Health Information
More informationVIRTUAL USER GROUP MEETING PLATFORM OVERVIEW
VIRTUAL USER GROUP MEETING PLATFORM OVERVIEW THE FORMFAST PLATFORM PRINT Industry-leading print automation FormFast Solutions Include: Barcoding Forms Admission Packet Automation On-Demand Forms Wristband
More informationFlexibility Coalition Luncheon PRIM&R Conference Baltimore, MD December 5, 2014
Updates from University of Southern California (USC) Welcome and introductions USC developing booklet about IRB reliance agreements USC webpage on reliance agreements Conference call will be held in Feb-March
More informationDRAFT NOT OFFICIAL GUIDANCE
DRAFT POINTS TO CONSIDER: Summary Requirement for Informed Consent Documents Not official guidance subject to change in accordance with regulatory requirements Standard Templates Working Group of the SMART
More informationTO MEMBERS OF THE FINANCE AND CAPITAL STRATEGIES COMMITTEE: DISCUSSION ITEM EXECUTIVE SUMMARY BACKGROUND
Office of the President TO MEMBERS OF THE FINANCE AND CAPITAL STRATEGIES : For Meeting of UCPATH UPDATE DISCUSSION ITEM EXECUTIVE SUMMARY This report provides a brief update on the recently-completed UCPath
More informationNIH Single IRB of Record (sirb) IRB MEMBER TRAINING SEPTEMBER 2016
NIH Single IRB of Record (sirb) IRB MEMBER TRAINING SEPTEMBER 2016 Historical Perspective of Reliance Agreements In past: reluctance to rely Reliance generally limited to affiliated institutions, programmatic
More informationNV Training: Benefit Transfer and Recertification. November 15, 2017
NV Training: Benefit Transfer and Recertification November 15, 2017 1 Housekeeping Audio is available through your computer s speakers The audience will remain on mute Enter questions at any time using
More information1 The Clinical Research Coordinator (CRC)... 1
TABLE OF CONTENTS Dedication... iii Introduction... xi 1 The Clinical Research Coordinator (CRC)... 1 Role and Responsibilities of the CRC...1 Personality and Skills... 3 Where Do CRCs Work?... 3 CRC Responsibilities...
More informationWebinar Starting Shortly!
Webinar Starting Shortly! Let us know where you are! Click the marker icon to open the annotation toolbar on the left. Click the arrow to mark where you are and click again to stop using it. WebEx Technology:
More informationTools, Templates, and Checklists for Streamlining IRB Protocol Review
Tools, Templates, and Checklists for Streamlining IRB Protocol Review Sharon Freitag, BSc Megan Kasimatis Singleton, JD, MBE, CIP May 5, 2016 Welcome! Nora Murphy Online Learning Coordinator PRIM&R 1 Content
More informationACA Operating Rules Update February nd National HIPAA Summit
ACA Operating Rules Update February 2014 22 nd National HIPAA Summit Status: ACA Mandated Operating Rules and Certification Mandated requirements available and should be in use in market Compliance in
More informationSage Accountant Partner Programme. For exceptional accountants
Sage Accountant Partner Programme For exceptional accountants Welcome Welcome to the Accountant Partner Programme, offering you award-winning support, insider knowledge and much more to take you and your
More informationAN EXECUTIVE S GUIDE TO BUDGETING FOR SECURITY INFORMATION & EVENT MANAGEMENT
WHITE PAPER AN EXECUTIVE S GUIDE TO BUDGETING FOR SECURITY INFORMATION & EVENT MANAGEMENT COST ANALYSIS OF TWO DELIVERY MODELS: SELF-MANAGED SIEM VS. MANAGED SIEM SERVICES AN EXECUTIVE S GUIDE TO BUDGETING
More informationPolicy & Procedure Management: Benchmarking Your Program
Policy & Procedure Management: Title Benchmarking Your Program Subtitle Findings from the largest Date research study conducted on policy management from NAVEX Global July 25, 2017 The audio to this webinar
More informationRegulatory Visits, Audits and Investigations
Regulatory Visits, Audits and Investigations The Role of the Compliance Officer Carole A. Klove, JD, RN, CHRC Juliann Tenney, JD, CHRC Welcome! The content of this presentation does not necessarily represent
More informationFinding flexibility in the regulations. Mariette Marsh, MPA, CIP HCCA 2017 Baltimore, MD June 5, Disclosures
Finding flexibility in the regulations Mariette Marsh, MPA, CIP HCCA 2017 Baltimore, MD June 5, 2017 Disclosures Nothing to disclose and all opinions are my own 2 1 Agenda What is flexibility? Case study
More informationFun & Profit with Dynamic Ads
Fun & Profit with Dynamic Ads Webinar Maddie Cary Point it Digital Marketing www.pointit.com 05.20.2015 1 @MaddieMarketer // @point_it // #PI_PPC Housekeeping Slide Raise your hand if you are having technical
More informationHuman Research Protection Program. Investigator Manual
Human Research Protection Program Revised July 7, 2014 HRP-910 7/7/2014 2 of 10 Table of Contents What is the purpose of this manual?... 3 What is Human Research?... 3 What is the Human Research Protection
More informationAN ACCESSIBLE EHR THAT SUPPORTS MENTAL HEALTH CLINICIANS. BehavioralChoice.com
AN ACCESSIBLE EHR THAT SUPPORTS MENTAL HEALTH CLINICIANS BehavioralChoice.com 1 2 About BehavioralChoice BehavioralChoice is as unique as the care you deliver to your clients. With BehavioralChoice, you
More informationRegulatory Documentation and Submissions for C2012 Clinical Trials DCP SOP #1
Regulatory Documentation and Submissions for C2012 Clinical Trials DCP SOP #1 Phone: 650.691.4400 Fax: 650.691.4410 Email: regulatory.ccsainc.com COMPLIANCE & STANDARDIZATION Rationale for Revision of
More informationSOCIETY OF RESEARCH ADMINISTRATORS ORLANDO FLORIDA OCTOBER 2018
SOCIETY OF RESEARCH ADMINISTRATORS ORLANDO FLORIDA OCTOBER 2018 CLINICAL TRIALS FINANCIAL MANAGEMENT ADMINISTRATIVE CHALLENGES & CONSIDERATIONS Agenda 1. Introduction 2. Challenges in Clinical Trial Financial
More informationImproving Data Accuracy With Governance, Definitions and Structure
Improving Data Accuracy With Governance, Definitions and Structure A Complimentary Webinar From healthsystemcio.com Your Line Will Be Silent Until Our Event Begins at 12:00 ET Thank You! Housekeeping Moderator
More informationP41: THE RISKS AND BENEFITS OF HEALTHCARE CONSOLIDATION ON INNOVATION AND CLINICAL RESEARCH IN HEALTH SYSTEMS AND HOSPITALS
1 P41: THE RISKS AND BENEFITS OF HEALTHCARE CONSOLIDATION ON INNOVATION AND CLINICAL RESEARCH IN HEALTH SYSTEMS AND HOSPITALS CONDUCTING DUE DILIGENCE AND THE COMPLIANCE RISK MITIGATION STRATEGIES TO HELP
More informationSage Accountant Partner Programme. For exceptional accountants
Sage Accountant Partner Programme For exceptional accountants Welcome Welcome to the Accountant Partner Programme, offering you award-winning support, insider knowledge and much more to take you and your
More informationInfoPath Retirement What You Need to Know
InfoPath Retirement What You Need to Know Agenda Company Overview InfoPath Retirement: What it means? InfoPath History Alternatives: How do I choose right one? Microsoft Product Roadmap What should I do
More informationData-Driven Strategies for Improved Site Activation and Patient Enrollment Forecasting
Data-Driven Strategies for Improved Site Activation and Patient Enrollment Forecasting Introduction PRESENTERS Mark Shapiro, MA, MBA Vice President, Clinical Development Clinipace Worldwide Cindy Venendaal,
More informationHow a Healthcare Analytics Company Used Non-Gated Content to More Than Double High-Quality Leads Session Title
How a Healthcare Analytics Company Used Non-Gated Content to More Than Double High-Quality Leads Session Title CHRIS KELLER Vice President of Marketing Health Catalyst Chris Keller Vice President of Marketing
More informationClearinghouse Roadmap to Testing ICD-10. Mary Rita Hyland CPO & VP Regulatory Affairs The SSI Group, Inc.
Clearinghouse Roadmap to Testing ICD-10 Mary Rita Hyland CPO & VP Regulatory Affairs The SSI Group, Inc. About The SSI Group, Inc. Founded in 1986, SSI s EHNAC certified healthcare claims clearinghouse
More informationCancer Center Clinical Trials Office
STANDARD OPERATING PROCEDURE PROCESS CHANGE MANAGEMENT SOP#: 1.2 Original Approval Date: 3/25/13 Version#: 1.0 Revision Dates: n/a 1.0 PURPOSE/BACKGROUND This SOP is meant to control changes that impact
More informationExternal IRB Review What Does it Mean for Your Institution
External IRB Review What Does it Mean for Your Institution Wesley G Byerly, Pharm.D. Associate Vice President for Research Integrity and Regulatory Affairs University of Connecticut and UCONN Health HCCA
More informationEffective Date: October 8, 2015 Policy Number: MHC_RP0301. Corporate Director, HRPP Institutional Official, HRPP
Policy Title: Education and Quality Improvement Program EQuIP Effective Date: October 8, 2015 Policy Number: Review Date: October 8, 2015 Section: Revised Date: Administrative Responsibility: Oversight
More informationActivities of the Korean Association of the Institutions Review Boards (KAIRB) in the year of Korea
Activities of the Korean Association of the Institutions Review Boards (KAIRB) in the year of 2002-2003 Korea October 18, 2003 Ock-Joo Kim, M.D., Ph.D. General Secretary of KAIRB (Seoul, Korea) I. Foundation
More informationUse of IRB Quality Metrics for Performance Assurance of the Ethics Committee
Use of IRB Quality Metrics for Performance Assurance of the Ethics Committee Pornpimon Adams FTM-EC Secretary Faculty of Tropical Medicine, Mahidol University Background Ethics Committee Faculty of Tropical
More informationBlended A.I. Christopher Connolly VP Solution Strategy. Where Bots and Automation Collide with the Power of the Human Touch
Blended A.I. Christopher Connolly VP Solution Strategy Where Bots and Automation Collide with the Power of the Human Touch THE BOT EVOLUTION Transactional Relationship Basics FAQ Content based search Mobile
More informationImplementing Good Clinical Practice at an Academic Research Institution
Implementing Good Clinical Practice at an Academic Research Institution Maintaining Essential Documents Partners Human Research Quality Improvement (QI) Program Stephen W. Hayes Outline Significance of
More informationThis document outlines the specifics of the training program that is being developed by M7 Training Solutions (MTS) for PJ Enterprises.
Project Plan This document outlines the specifics of the training program that is being developed by M7 Training Solutions (MTS) for PJ Enterprises. Project Name This phase of our project is called New
More informationU.S. FDA CENTER FOR DEVICES AND RADIOLOGICAL HEALTH UPDATE. Jeff Shuren Director Center for Devices and Radiological Health
U.S. FDA CENTER FOR DEVICES AND RADIOLOGICAL HEALTH UPDATE Jeff Shuren Director Center for Devices and Radiological Health 21 ST CENTURY CURES ACT IMPLEMENTATION Provision Implementation activities completed
More informationAudio Conference Service from Airtel
Audio Conference Service from Airtel About our Product-ACS Connects multiple parties from different locations with a normal telephone or Mobile. Eliminates the need to have a meeting at a specific physical
More informationConstructing an etmf 12/2/2011. consider your current etmf structure!! The do s and don ts of EDM. Disclaimer
Constructing an etmf The do s and don ts of EDM Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug
More information2016 CIO AS BUSINESS DEVELOPER. CapaSystems - CIO as Business Developer 1 7
2016 CIO AS BUSINESS DEVELOPER CapaSystems - CIO as Business Developer 1 7 EXECUTIVE SUMMARY It is crucial that businesses CIOs are able to identify, select and evaluate the IT services that provide maximum
More informationCollaboration and Efficiency in IRB review of Multi-Site Research
Collaboration and Efficiency in IRB review of Multi-Site Research Human Subject Research Community Conference University of Miami Student Activities Center (SAC) September 11, 2014 Cynthia Hahn VP, Clinical
More informationStreamlining IRB Procedures for Expanded Access
Streamlining IRB Procedures for Expanded Access Marjorie A. Speers, Ph.D. Executive Director, WCG Foundation Richard Klein Director, FDA Patient Liaison Program Office of Health and Constituent Affairs
More informationICD-10 Survey Results Webinar. June 17, :00 2:30 pm ET
ICD-10 Survey Results Webinar June 17, 2015 1:00 2:30 pm ET **Audio for this webinar streams through the web. Please make sure the sound on your computer is turned on and you have speakers. If you need
More informationSiebel CRM On Demand Administrator Rollout Guide
Siebel CRM On Demand Administrator Rollout Guide This Administrator Rollout Guide consolidates tips and lessons learned from implementing Siebel CRM On Demand, discusses your role as an administrator,
More informationClinical Trial Transparency UK perspective
Clinical Trial Transparency UK perspective Dr Bina Rawal Medical, Innovation & Research Director Association of the British Pharmaceutical Industry January 2014 1 Outline Transparency timeline Campaign
More informationOffice Of Clinical Trials. Christine Nelson, RN, BSN, MBA, CCRC
Office Of Clinical Trials Christine Nelson, RN, BSN, MBA, CCRC OCT Mission Statement The mission of the Office of Clinical Trials (OCT) is to serve the Carolina research community by improving the quality
More informationIND Development Process Published on ResearchGo UCLA (
IND Development Process IND Development Overview The Pre-IND Process The IND Study Protocol Preparing the Initial IND Submission Filing the IND Maintaining the IND IND Templates, Education and Useful Links
More informationOperational Readiness for Healthcare Survey
Operational Readiness for Healthcare Survey Title of Presentation Presenter Title of Presentation Speakers Featuring: Dr. Barbara Duffy, DHSc, MPH, CPHQ, LHRM, RN President, Barb Duffy Consulting LLC Hosted
More informationClinicalTrials.gov Registration and Results Reporting: Updates and Recent Activity
Vol. 7, No. 2, February 2011 Can You Handle the Truth? ClinicalTrials.gov Registration and Results Reporting: Updates and Recent Activity By Matthew Lester and Barbara Godlew The Food and Drug Administration
More informationWhy Industry Collaborations Matter TransCelerate BioPharma, Inc.
Why Industry Collaborations Matter TransCelerate BioPharma, Inc. Jackie Kent Eli Lilly & Co. Shared Investigator Platform Initiative Leader, TransCelerate BioPharma Inc. Introduced by: Carlo Maccarrone
More informationGuiding Principles. Mission: Vision: Values: Overarching Principles
Guiding Principles To ensure that the organization effectively achieves these goals and objectives and experiences a uniformly successful implementation, we have developed a series of guiding principles
More informationCUSTODIAN INTERVIEWS MAXIMIZING A VALUABLE OPPORTUNITY
CUSTODIAN INTERVIEWS MAXIMIZING A VALUABLE OPPORTUNITY WELCOME Thank you for joining Numerous diverse attendees Today s topic and presenters This is an interactive presentation You will receive slides,
More informationHow to Significantly Reduce Network Costs in These Turbulent Times
Gartner Webinar How to Significantly Reduce Network Costs in These Turbulent Times Neil Rickard Research VP 24 June 2009 2008 Gartner Inc. and/or its affiliates. All rights reserved. These materials belong
More informationINTERNAL AUDIT S ROLE IN MONITORING AND CONTROLLING INTERNATIONAL EXPOSURE
INTERNAL AUDIT S ROLE IN MONITORING AND CONTROLLING INTERNATIONAL EXPOSURE NOVEMBER 28, 2017 Michael Vierheller Managing Director, Risk Advisory Services CPE AND SUPPORT CPE Participation Requirements
More informationGetting ready for 2019
Getting ready for 2019 Quick wins to improve your Global Mobility program in the coming year 2018 Worldwide ERC December 11, 2018 11 a.m. EST/4 p.m. GMT Our thanks to today s sponsor: Getting ready for
More informationHow Cisco IT Developed a Self-Service Model for Build and Deploy
Cisco IT Case Study Self-Service Build and Deploy How Cisco IT Developed a Self-Service Model for Build and Deploy Automating application delivery speeds up the pace of innovation and saves 32 developer
More informationTier Assessment/Setting - Quick Guide to Competency Levels
Tier Assessment/Setting - Quick Guide to Competency Levels RESEARCH OPERATIONS Competency Fundamental Skilled Advanced Interactions with IRB Candidate has used the system to successfully submit documents
More informationTerry Sousa UMass Medical School PRS Administrator for Clinicaltrials.gov
Terry Sousa UMass Medical School PRS Administrator for Clinicaltrials.gov What is ClinicalTrials.gov? National registry of federally and privately supported research studies Why register and report results?
More informationTrends in Oversight of Human Research Protections?
Trends in Oversight of Human Research Protections? Greg Koski, PhD, MD Associate Professor, Harvard Medical School Senior Scientist, James Mongan Institute for Health Policy Former Director, Office for
More informationCollaborative Research Opportunity January 18th, 2019
Collaborative Research Opportunity Customer Lifetime Value for Business-to-Business Customers of a Leading B2B Supplier of Industrial Products and Services January 18 th, 2019 Introductions Mary Purk Executive
More information8 Most Significant Proposed Changes to the Common Rule. Susan L. Rose Office for the Protection of Research Subjects (OPRS)
8 Most Significant Proposed Changes to the Common Rule Susan L. Rose Office for the Protection of Research Subjects (OPRS) Overview 1. Informed Consent 2. Use of Biospecimens 3. Activities Excluded from
More informationWebinar Reminders. 1. Everyone is muted. Press *6 to mute yourself and *7 unmute. 2. Remember to chat in questions along the way!
Webinar Reminders 1. Everyone is muted. Press *6 to mute yourself and *7 unmute. 2. Remember to chat in questions along the way! 3. Webinar will be recorded, posted on CCI s website, and sent out via email.
More informationPREP Course 24: Defining the Differences between FDA and OHRP regulations. Presented by: Hallie Kassan Dorean Flores Office of the IRB
PREP Course 24: Defining the Differences between FDA and OHRP regulations Presented by: Hallie Kassan Dorean Flores Office of the IRB CME Disclosure Statement The North Shore LIJ Health System adheres
More informationApplicability of US Regulations to Canadian Research
Applicability of US Regulations to Canadian Research Mary Kate Needler Capital District Health Authority Halifax, Nova Scotia, Canada N2 Stakeholder Meeting August 18, 2014 MK s Conventions: 1. US Regulation
More informationCAQH CORE. EFT/ERA Implementation Status and Development of Operating Rules for Remaining HIPAA Transactions
CAQH CORE EFT/ERA Implementation Status and Development of Operating Rules for Remaining HIPAA Transactions Testimony Provided to the Subcommittee on Standards National Committee on Vital and Health Statistics
More informationThis session will begin promptly at the scheduled start time. We appreciate your patience.
WELCOME + The meeting room is currently muted. Audio: Use your computer speakers, or dial 1-800- 768-2983; Access code 8460751 Mute: Your line has been muted as a courtesy to others. Q/A: There will be
More informationYour guide to ICD-10 success
Your guide to ICD-10 success This sample contains pages from 3M s ICD-10 eguide. Click here to download the full version. How to use this guide This ICD-10 eguide provides a basic overview of steps hospitals
More informationLockheed Martin RMS Deploys Fiori-Based Time Entry in the NS2 Cloud
SAP North America Aerospace and Defense Innovation Days Lockheed Martin RMS Deploys Fiori-Based Time Entry in the NS2 Cloud Mike Lansing, Director of Applications - Lockheed Martin Rotary and Mission Systems
More informationMCW Office of Research Standard Operating Procedure
MCW Office of Research Standard Operating Procedure USE AND STORAGE OF INVESTIGATIONAL DEVICES Unit: Applies to: Human Research Protections Program (HRPP), Office of Research MCW Faculty and Staff involved
More informationEnterprise Research Risk
Enterprise Research Risk Managing All the Moving Parts Erika Stevens, MA, Senior Manager Healthcare Advisory Tina Noonan, MBA,CHRC,CIP Director, Research and Regulatory Affairs Learning objectives Describe
More informationHHSC Electronic Visit Verification. Module 6 EVV Process Flow: Beginning to End April 1, 2019
HHSC Electronic Visit Verification Module 6 EVV Process Flow: Beginning to End April 1, 2019 Introduction This is Module 6 of the EVV Tool Kit: EVV Process Flow: Beginning to End. EVV Tool Kit: A collection
More informationUnderstanding Reporting Obligations to the IRB
Understanding Reporting Obligations to the IRB fully accredited since 2006 May 13 & 15, 2014 Mitchell E. Parrish, JD, RAC, CIP Regulatory Attorney 2 3 WEBINAR HOUSEKEEPING Questions & Answers Feel free
More informationOSRA Updates. RAPID September 11 th 2017
OSRA Updates RAPID September 11 th 2017 NIH Forms E COMING SOON FORMS E What is Changing? Human subjects, inclusion enrollment and clinical trials information will be collected on a single PHS Human Subjects
More informationStatement of Work. 1.0 Executive Summary. 2.0 Features & Benefits NetBotz Appliance Configuration Service. Installation Service
Statement of Work - 1 - NetBotz Appliance Configuration Service NetBotz Appliance Configuration Installation Service Service 1.0 Executive Summary Table of Contents 1.0 Executive Summary 2.0 Features &
More information